Search research articles
Contact Us
Filters
Showing results (271-280 of 402) with videos related to
Page
of 41
Sort By:
Cell Death and Differentiation
|
August 24, 1999
The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis
T Oikawa, T Yamada, F Kihara-Negishi, et al.
Oncogene
|
October 11, 2001
In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression
F Kihara-Negishi, H Yamamoto, M Suzuki, et al.
Cancer Research
|
June 15, 1987
Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld)
T Itaya, S Yamagiwa, F Okada, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|
September 1, 1980
[Pseudomembranous colitis due to Clostridium difficile and the new therapeutic approach (author's transl)]
T Kuratsuji, K Yamada, T Oikawa, et al.
Oncogenesis
|
September 13, 2016
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance
A Hashimoto, S Hashimoto, H Sugino, et al.
Clinical Transplantation
|
November 25, 2000
Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM)
A Takeda, K Uchida, T Haba, et al.
The Journal of Antibiotics
|
May 1, 1993
Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase
T Oikawa, H Ashino, M Shimamura, et al.
International Journal of Cancer
|
September 15, 1976
Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin grafts
M Hosokawa, M Imamura, T Oikawa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1983
Sequential serum measurements of thyrotropin binding inhibitor immunoglobulin G in transient familial neonatal hypothyroidism
M Iseki, M Shimizu, T Oikawa, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|
July 1, 1986
[Clinical significance of hyper-HDL-cholesterolemia. II. Characteristics in clinical features]
Y Hata, M Yamamoto, T Oikawa, et al.
Page
of 41
Search research articles
Search
Showing results (271-280 of 402) with videos related to
Sort By:
Page
of 41
Cell Death and Differentiation
|
August 24, 1999
The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis
T Oikawa, T Yamada, F Kihara-Negishi, et al.
Oncogene
|
October 11, 2001
In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression
F Kihara-Negishi, H Yamamoto, M Suzuki, et al.
Cancer Research
|
June 15, 1987
Xenogenization of a mouse lung carcinoma (3LL) by transfection with an allogeneic class I major histocompatibility complex gene (H-2Ld)
T Itaya, S Yamagiwa, F Okada, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|
September 1, 1980
[Pseudomembranous colitis due to Clostridium difficile and the new therapeutic approach (author's transl)]
T Kuratsuji, K Yamada, T Oikawa, et al.
Oncogenesis
|
September 13, 2016
ZEB1 induces EPB41L5 in the cancer mesenchymal program that drives ARF6-based invasion, metastasis and drug resistance
A Hashimoto, S Hashimoto, H Sugino, et al.
Clinical Transplantation
|
November 25, 2000
Acute humoral rejection of kidney allografts in patients with a positive flow cytometry crossmatch (FCXM)
A Takeda, K Uchida, T Haba, et al.
The Journal of Antibiotics
|
May 1, 1993
Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase
T Oikawa, H Ashino, M Shimamura, et al.
International Journal of Cancer
|
September 15, 1976
Inhibition of syngeneic tumor growth in rats immunized with allogeneic skin grafts
M Hosokawa, M Imamura, T Oikawa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 1, 1983
Sequential serum measurements of thyrotropin binding inhibitor immunoglobulin G in transient familial neonatal hypothyroidism
M Iseki, M Shimizu, T Oikawa, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
|
July 1, 1986
[Clinical significance of hyper-HDL-cholesterolemia. II. Characteristics in clinical features]
Y Hata, M Yamamoto, T Oikawa, et al.
Page
of 41